Valor20202021202220232024Total de passivos523.7 M782.02 M773.95 M249.74 M416.27 MCapital total2.04 B1.61 B6.45 B5.19 B5.29 BTotal de passivos e patrimônio líquido2.59 B2.39 B7.22 B5.44 B5.71 BDívida total210.03 M————Dívida líquida210.03 M————
Roivant Sciences Ltd. - Common Shares
Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel.